Skip to main content
Premium Trial:

Request an Annual Quote

Trying Not to Encroach on NIH Mission, Genomes to Life Changes Name

NEW YORK, May 20 (GenomeWeb News) - The Department of Energy's Genomes to Life program has changed its name to Genomics: GTL, according to a DOE official.

 

Ari Patrinos, director of biological and environmental research at the DOE, said the project changed its name after members of a congressional subcommittee that oversees the US National Institutes of Health voiced concern that the original name may lead people to infer that the program deals with human biology - traditionally an NIH endeavor, and not a DOE responsibility.

 

Patrinos stressed that the overall goals and mission of Genomes to Life have not changed. He said the name change began several months ago, and that it is a gradual process. "It hasn't been an abrupt change," he said.

 

The name still appears in many places -- for instance, the Genomics: GTL website address still reads www.doegenomestolife.org -- and "a lot of people still use" the old name, said Patrinos.

 

Some members of the House Energy and Commerce Committee, an authorizing group that has jurisdiction over NIH programs, "were concerned that the name of the [Genomes to Life] program made it sound, at least to them, that it was an NIH program," Patrinos told GenomeWeb News ­this week. "For the purposes of clarification, they encouraged us to change the name." The DOE is overseen by the House Energy and Water Committees.

 

He said the new name is a "more neutral term that does not necessarily have any particular affiliation with a specific agency."

 

Patrinos said the Genomes to Life name gave members of the commission "the impression that it had to do with human biology. ... The GTL program is focused on energy applications" such as bioremediation, clean energy production, and carbon sequestration.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.